Global BioAccess Fund
Venture Capital And Private Equity Principals
New York, United States
10 employees
- Employees
- 10
- Contacts
- 4
- Emails
- 4
- Phones
- 3
Global BioAccess Fund Overview
- Headquarters
- New York, United States
- Website
- globalbioaccess.com
- Industry
- Venture Capital And Private Equity Principals
- Employees
- 10
- Founded
- 2021
- NAICS
-
Miscellaneous Intermediation
About Global BioAccess Fund
At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.
Global BioAccess Fund Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 3
- 75.0% coverage
Global BioAccess Fund Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Kevin Cyr, Md | Stanford Biodesign Fellow - Life | Los Angeles, California, United States |
Email
Phone
|
| Sally Adua | Life Science Venture Capital | New York, United States |
Email
Phone
|
| Lisa Wisniewski, Phd | Managing Director at Global Bioaccess | New York City Metropolitan Area, United States |
Email
Phone
|
| Sonia Gulati | Life Science Venture Capital | New York City Metropolitan Area, United States |
Email
|
Employees by Management Level
Individual contributor
3 profiles
Director
1 profile
Compare Similar Companies to Global BioAccess Fund
Norwest
Venture Capital And Private Equity Principals
Atlas Venture
Venture Capital And Private Equity Principals
ShiraTronics, Inc.
Medical Equipment Manufacturing
Nuvig Therapeutics Inc.
Biotechnology Research
Matrix Capital Management
Investment Management
Avego
Investment Management
RM Global Partners
Investment Banking
OncoPep, Inc.
Biotechnology Research
Tellus BioVentures
Venture Capital And Private Equity Principals
Hatch Biofund Management
Venture Capital And Private Equity Principals